Sainte-Foy-lès-Lyon, France
Sainte-Foy-lès-Lyon, France

Time filter

Source Type

Patent
Ceva Sante Animale | Date: 2016-05-10

The present invention further relates to ivermectin, most preferably formulated as an implant for administration of pet and domestic animals. These formulations provide long term protection against Dirofilaria parasites, without the risks for secondary adverse events of conventional formulations. Preferred formulations are implants and are administered at least twice a year, once a year, or at least once in 18 months, up to 24 months.


Patent
Ceva Sante Animale | Date: 2014-04-10

The present invention relates to novel immunogenic polypeptides and their use in vaccine compositions. The invention also relates to nucleic acids, vectors and cells which express the polypeptides and the uses thereof. The polypeptides of the invention more specifically comprise an immunogenic domain and a cell membrane addressing domain which is derived from a B5R gene. The invention is particularly suited to produce vaccines for non-human animals, particularly for vaccinating swine against PCV2 infection.


Patent
Ceva Sante Animale | Date: 2014-09-05

The present invention relates recombinant viruses and the uses thereof. More particularly, the invention relates to novel recombinant Mareks disease viruses encoding polypeptide(s) of interest, and their use to express or deliver such polypeptides to animals, particularly poultry. The invention is particularly suited to vaccinate poultry against avian pathogens.


Patent
Ceva Sante Animale | Date: 2016-06-22

The present invention relates to novel recombinant swinepox viruses and their use in vaccine compositions. The recombinant swinepox viruses of the invention are produced by inserting one or more foreign genes into IL-18 binding protein (IL18bp) gene of swinepox virus. The invention is particularly suited to produce swine vaccines, particularly for vaccinating swine against PCV2 infection.


Patent
Ceva Sante Animale | Date: 2015-03-11

The present invention relates recombinant viruses and the uses thereof. More particularly, the invention relates to novel recombinant Mareks disease viruses encoding polypeptide(s) of interest, and their use to express or deliver such polypeptides to animals, particularly poultry. The invention is particularly suited to vaccinate poultry against avian pathogens.


Patent
Ceva Sante Animale | Date: 2015-12-16

The present invention relates to a composite comprising a composition of pheromones and a composite foam, said composite can be for a use to prevent and / or treat of at least one medical or behavioral stress problem of a non-human mammal. It also relates to a device comprising said composite and to a method for preventing and / or treating of at least one medical or behavioral stress problem of a non-human mammal by implementing said composite or device.


Multi-layered plastic polymeric container in a bottle form useful for the storage of a composition, which comprises an inner polymeric layer and an outer polymeric layer, a central gas barrier layer and adhesive layers, wherein the outer and inner layers comprise a mixture of polymers and antioxidants


Patent
Ceva Sante Animale | Date: 2016-08-03

The present invention relates to recombinant MDV1 viruses and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.


Patent
Ceva Sante Animale | Date: 2016-05-25

The invention relates to a parenteral composition, wherein the formulation comprises eprinomectin and a vehicle comprising dimethylsulfoxide. It also relates to said composition for use in the treatment of infections caused by ectoparasites and endoparasites.


The invention relates to novel veterinary compositions comprising torasemide or a pharmaceutically acceptable salt thereof and administered in domestic animals according to a predetermined dosage for symptomatic treatment of pulmonary edema associated with heart failure.

Loading Ceva Sante Animale collaborators
Loading Ceva Sante Animale collaborators